Licofelone attenuates MPTP-induced neuronal toxicity: Behavioral, biochemical and cellular evidence

Inflammopharmacology

Volumn 18, Issue 5, 2010, Pages 223-232

  Gupta, Amit ^a   Kumar, Anil ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine (MPTP); Cyclooxygenase (COX); Licofelone (LCF); Lipooxygenase (LOX); Neuroinflammation; Parkinson's disease (PD)

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CASPASE 3; LICOFELONE; LIPID; MALONALDEHYDE; NITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE; THIOL; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CATATONIA; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; ENZYME ACTIVITY; LIPID PEROXIDATION; LOCOMOTION; MALE; MITOCHONDRION; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BEHAVIOR, ANIMAL; CASPASE 3; CYCLOOXYGENASE INHIBITORS; LIPID PEROXIDATION; LIPOXYGENASE INHIBITORS; MICE; MITOCHONDRIA; MOTOR ACTIVITY; MPTP POISONING; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRITES; OXIDATIVE STRESS; PYRROLES;

EID: 77957018445     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-010-0052-6     Document Type: Article

References (53)

1. Y Agid 1991 Parkinson's disease: pathophysiology Lancet 337 1321 1324 1674304
2. JA Aguirre G Leo R Cueto B Andbjer A Naylor AD Medhurst, et al. 2008 The novel cyclooxygenase-2 inhibitor GW637185x protects against l-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine toxicity Neuroreport 19 657 660 18382281
3. BM Babior RS Kipner JT Cerutte 1973 Biological defense mechanism. The production by leukocytes of superoxide, a potential bacterial agent J Clin Invest 52 741 744 4346473
4. AL Bartels KL Leenders 2007 Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET Mov Disord 22 1852 1856 17592621
5. SB Berman TG Hastings 1999 Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J Neurochem 73 1127 1137 10461904
6. P Bias A Buchner B Klesser S Laufer 2004 The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from randomized, controlled trial Am J Gastroenterol 99 611 618 15089890
7. MA Bray AW Ford-Hutchinson MJ Smith 1981 Leukotriene B4: an inflammatory mediator in vivo Prostaglandins 22 213 222 6270742
8. DS Bredt SH Snyder 1990 Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme Proc Natl Acad Sci USA 87 682 685 1689048
9. M Chalimoniuk N Lukacova J Marsala J Langfort 2006 Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice Neuroscience 141 1033 1046 16716528
10. DA Drechsel LP Liang M Patel 2007 1-Methyl-4-phenylpyridinium-induced alterations of glutathione status in immortalized rat dopaminergic neurons Toxicol Appl Pharmacol 220 341 348 17395226
11. GL Ellman 1959 Tissue sulfhydryl groups Arch Biochem Biophys 82 70 77 13650640
12. M Etminan BC Carleton A Samii 2008 Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study J Clin Neurosci 15 576 577 18343119
13. ZH Feng TG Wang DD Li P Fung BC Wilson B Liu, et al. 2002 Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra Neurosci Lett 329 354 358 12183047
14. S Fiorucci R Meli M Bucci G Cirino 2001 Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy Biochem Pharmacol 62 1433 1438 11728379
15. AG Gornall CJ Bardawill MM David 1949 Determination of serum proteins by means of the biuret reaction J Biol Chem 177 751 766 18110453
16. A Gupta A Dhir A Kumar SK Kulkarni 2009 Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats Pharmacol Biochem Behav 94 219 226 19666045
17. A Gupta A Dhir A Kumar SK Kulkarni 2010 Effect of preferential cyclooxygenase-2 (COX-2)-inhibitor against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced striatal lesions in rats: behavioral, biochemical and histological evidences Indian J Exp Biol 48 577 585
18. B Halliwell 1992 Reactive oxygen species and the central nervous system J Neurochem 59 1609 1623 1402908
19. TG Hastings 1995 Enzymatic oxidation of dopamine: the role of prostaglandin H synthase J Neurochem 64 919 924 7830086
20. EC Hirsch T Breidert E Rousselet S Hunot A Hartmann PP Michel 2003 The role of glial reaction and inflammation in Parkinson's disease Ann N Y Acad Sci 991 214 228 12846989
21. RL Hunter N Dragicevic K Seifert DY Choi M Liu HC Kim, et al. 2007 Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system J Neurochem 100 1375 1386 17254027
22. Kalonia H, Kumar P, Kumar A, Nehru B (2009) Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats. Inflammopharmacol 17:211-219
23. YS Kim TH Joh 2006 Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease Exp Mol Med 38 333 347 16953112
24. TE King RL Howard 1967 Preparations and properties of soluble NADH dehydrogenases from cardiac muscle Methods Enzymol 10 275 284
25. C Knott G Stern GP Wilkin 2000 Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2 Mol Cell Neurosci 16 724 739 11124893
26. SK Kulkarni VP Singh 2007 Licofelone-a novel analgesic and anti-inflammatory agent Curr Top Med Chem 7 251 263 17305568
27. S Laufer S Tries J Augustin G Dannhardt 1994 Pharmacological profile of a new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase Arzneimittelforschung 44 629 636 8024637
28. RA Lewis KF Austen RJ Soberman 1990 Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases N Engl J Med 323 645 655 2166915
29. Z Li DY Choi EJ Shin RL Hunter CH Jin MB Wie, et al. 2008 Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity Neurosci Lett 445 1 6 18760329
30. J Martel-Pelletier D Lajeunesse P Reboul JP Pelletier 2003 Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs Ann Rheum Dis 62 501 509 12759283
31. RL Mosley EJ Benner I Kadiu M Thomas MD Boska K Hasan, et al. 2006 Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease Clin Neurosci Res 6 261 281 18060039
32. T Mosmann 1983 Rapid colorimetric assay for cellular growth survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 6606682
33. H Ohkawa N Ohishi K Yagi 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 351 358 36810
34. S Przedborski V Jackson-Lewis R Yokoyama T Shibata VL Dawson TM Dawson 1996 Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity Proc Natl Acad Sci USA 93 4565 4571 8643444
35. A Przybyłkowski I Kurkowska-Jastrzebska I Joniec A Ciesielska A Członkowska 2004 Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse Brain Res 1019 144 151 15306248
36. V Raghavendra JN Agrewala SK Kulkarni 2000 Melatonin reversal of lipopolysaccharide-induced thermal and behavioral hyperalgesia in mice Eur J Pharmacol 395 15 21 10781668
37. KD Rainsford 2007 Anti-inflammatory drugs in the 21st century Subcell Biochem 42 3 27 17612044
38. A Singh SK Kulkarni 2002 Role of adenosine in drug-induced catatonia Indian J Exp Biol 40 882 888 12597016
39. VP Singh CS Patil SK Kulkarni 2005 Effect of licofelone against NSAIDs-induced gastrointestinal ulceration and inflammation Indian J Exp Biol 43 247 253 15816411
40. VP Singh CS Patil SK Kulkarni 2006 Anti-inflammatory effect of licofelone against various inflammatory challenges Fundam Clin Pharmacol 20 65 71 16448396
41. A Slivka G Cohen 1985 Hydroxyl radical attack on dopamine J Biol Chem 260 15466 15472 2999117
42. RJ Smeyne V Jackson-Lewis 2005 The MPTP model of Parkinson's disease Brain Res Mol Brain Res 134 57 66 15790530
43. MB Spina G Cohen 1989 Dopamine turnover and glutathione oxidation: implications for Parkinson disease Proc Natl Acad Sci USA 86 1398 1400 2919185
44. K Sriram DB Miller P O'Callaghan 2006 Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha J Neurochem 96 706 718 16405514
45. P Teismann K Tieu DK Choi DC Wu A Naini S Hunot M Vila V Jackson-Lewis S Przedborski 2003 Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration Proc Natl Acad Sci USA 100 5473 5478 12702778
46. S Theodore S Cao PJ McLean DG Standaert 2008 Targeted overexpression of human alphasynuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease J Neuropathol Exp Neurol 67 1149 1158 19018246
47. KF Tipton TP Singer 1993 Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds J Neurochem 61 1191 1206 8376979
48. S Tries S Laufer 2001 The pharmacological profile of ML 3000: a new pyrrolizine derivative inhibiting the enzymes cyclooxygenase and 5-lipoxygenase Inflammopharmacology 9 113 124
49. S Tries W Neupert S Laufer 2002 The mechanism of action of the new anti-inflammatory compound ML3000: inhibition of 5-LOX and COX-1/2 Inflamm Res 51 135 143 12005204
50. M Vila S Przedborski 2003 Targeting programmed cell death in neurodegenerative diseases Nat Rev Neurosci 4 365 375 12728264 (Pubitemid 37280175)
51. M Vila D Ramonet C Perier 2008 Mitochondrial alterations in Parkinson's disease: new clues J Neurochem 107 317 328 18680555
52. AD Wahner JM Bronstein YM Bordelon B Ritz 2007 Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease Neurology 69 1836 1842 17984451
53. H Yokoyama H Kuroiwa R Yano T Araki 2008 Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease Neurol Sci 29 293 301 18941931